TechNavio today launched its report Erythropoietin Market in Japan 2011“2015 based on an in-depth study focusing exclusively on Japan. The report aims to aid decision makers™ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio™s Healthcare team said; The onset of patent expiration in the near future in the Erythropoietin market in Japan will provide an opportunity for many local and global players to enter the market. Looking at the opportunity ahead, pharmaceutical companies are developing biosimilars for the existing erythropoietin injections available in the market. For instance, the biosimilar epoetin alpha of Pfizer Inc. is set to enter the market in Japan in 2013.
According to the report, the Japanese Society for Dialysis Therapy found that there is a significant increase in patients undergoing dialysis for renal anemia, which shortens the survival of red blood cells (RBC), resulting in cardiac complications, and the number of chronic kidney disease patients is expected to increase in the near future. Erythropoietin is an effective drug which is administered in the form of an injection to treat renal anemia by increasing the survival of RBC. Hence, this leads to the growth of the market in Japan in terms of revenue generation.
Further, the report also discusses that there are several adverse side effects associated with the use of erythropoietin and this inhibits the growth of the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit https://www.technavio.com/content/erythropoietin-market-japan-2011-2015
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Report “ Erythropoietin Market in Japan 2011“2015
